Use Of Oral Itraconazole In Patients With Locally Limited Basocellular Carcinoma Of Skin.

Summary

Patients with localized basocellular carcinoma of the skin, will receive oral Itraconazole, 200 mg twice daily, for 60 days, prior to curative intent surgery.

Timeline

Start

2018-01-05

Primary completion

2020-12-01

Completion

2021-06-01

Drugs

Indications